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LETTER TO THE EDITOR
Uncommon Presentation of Craniopharyngioma
With Anemia in an Adolescent
To the Editor: Craniopharyngioma most commonly
presents with symptoms related to increased intra-
cranial pressure, such as headache and vomiting [1,2].
Less common presenting symptoms are secondary to the
invasion of the neighboring structures, which include
the pituitary, the hypothalamus, the optic pathways, and
the third ventricle. Visual and endocrine abnormalities
are usually present at initial evaluation although only a
minority of patients seeks medical attention because of
symptoms related to these abnormalities [1,3,4]. Anemia
is a common, nonspecific finding in the ambulatory
pediatric practice but constitutes an unusual initial presen-
tation for craniopharyngioma. We present the case of a
13-year-old female who was referred for the evaluation of
mild normocytic anemia and whose further investigation
led to the diagnosis of panhypopituitarism secondary to
craniopharyngioma.
The patient’s academic performance had deteriorated
over the last 6 months, which instigated the investigation
for anemia. She also reported fatigue, constipation, and
weight gain of 5 pounds in the last 6 months despite a
poor appetite. She denied headache or visual symptoms.
Hermenarche had occurred a year prior to her presentation
and her menstrual periods were regular but lasted only
2 days and consisted of spotting. The birth and past
medical history were unremarkable. She was not taking
any medications. The family history was significant for
hypothyroidism in a 29-year-old sister and was otherwise
negative. Aside from delayed puberty (Tanner stage II for
breasts and Tanner stage I for pubic and axillary hair), the
physical examination was essentially unremarkable, with
no focal neurologic findings.
White blood cell count was 4,800/mm3 with a differen-
tial of 29% neutrophils, 58% lymphocytes, 8% mono-
cytes, and 5% eosinophils. Hemoglobin was 10.9 g/dl and
the red blood cell count was 3.71 million/mm3. The
platelet count and the absolute reticulocyte count were
within normal range. Red blood cells were normocytic and
the other red cell indices were normal. Sedimentation rate,
serum aminotransferases, bilirubin, blood urea nitrogen,
and creatinine were within normal range.
Our patient’s symptoms (weight gain despite loss
of appetite, fatigue, worsening school performance,
amenorrhea and constipation) suggested the presence of
hypothyroidism.
Serum levels of free thyroxine and total thyroxin were
low (0.5 ng/dl and 3.8 mg/dl, respectively) in the face
of a normal thyroid stimulating hormone (TSH) level
(1.94 m IU/ml). The anti-thyroglobulin and antimicro-
somal antibodies were negative. The inappropriate TSH
response to low thyroxine levels, coupled with other ab-
normal findings (delayed puberty and lymphocyte pre-
dominance in the white blood cell differential) further led
to a clinical suspicion of hypopituitarism in our patient.
Serum levels of A.M. cortisol, insulin like growth factor-1
(IGF-1), IGF binding protein-3, follicle stimulating
hormone, and luteinizing hormone levels were also low,
establishing a diagnosis of hypopituitarism. Serum pro-
lactin level was within normal range. The radiological
bone age revealed mild delay in skeletal maturity. Urine
and serum osmolality were not suggestive of diapedes
insipidus.
A magnetic resonance imaging of the brain revealed a
sellar/suprasellar lesion, 2.5 cm in diameter, demonstrat-
ing hyperintense signal in T1-weighted images, most
likely representing a craniopharyngioma. The sella turcica
was widened and a normal pituitary and infundibulum
were not seen. A subsequent computerized tomographic
scan showed a rim of calcification within the lesion.
Automated perimetry using Humphrey field analyzer re-
vealed bitemporal hemianopia.
The patient underwent bifrontal craniotomy and total
resection of the tumor. The histologic examination of the
tumor revealed dense fibrous tissue and cystic spaces lined
by squamous epithelial cells with peripheral palisading
mimicking adamantinoma of the jaw, characteristic of
craniopharyngioma. Post-operatively the patient devel-
oped diabetes insipidus and monocular diplopia. She was
started on oral thyroxine, hydrocortisone, and desmopres-
sin supplementation and the hemoglobin rose from 10.9 to
12.2 g/dl 3 months after surgery.
Although an uncommon presenting symptom for
craniopharyngioma, anemia may be commonly discovered
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in the initial evaluation of cases of craniopharyngioma
presenting with other symptoms. Anemia was detected in
22% of patients with a pituitary tumor and 41% of patients
with craniopharyngioma [5]. The anemia encountered
in these tumors is a manifestation of the endocrine
deficiency, which includes hypothyroidism, hypocortiso-
lism and androgen deficiency in males [6,7]. The re-
solution of the anemia with hormonal supplementation
alone observed in our case supports its endocrine basis.
Clinicians evaluating isolated hypoproliferative normo-
cytic anemia (i.e., low or normal reticulocyte count)
should exclude acute infection, renal disease, hepatic
disease, transient erythroblastopenia of childhood and
hypothyroidism as a potential cause of anemia [7,8].
Accompanying absolute or relative lymphocytosis and
eosinophilia usually suggests hypocortisolism and should
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